Story · Medicine & Biotech

[Interview] eMotiv says 40% of ADHD digital therapy users return for second course

1 outlet · first reported by Korea Biomedical Review 18h ago

Coverage, in order

  1. 18h ago
    Korea Biomedical Review South Korea obscure interview
    [Interview] eMotiv says 40% of ADHD digital therapy users return for second course

    About 40 percent of children using eMotiv's attention-deficit/hyperactivity disorder (ADHD) digital therapeutic (DTx) STAR RUCKUS have returned for a second four-week course, the company said, as it seeks to position the game-based treatment as an alternative to medication despite experts' calls for

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.